Literature DB >> 21961704

Interstitial lung disease in rheumatoid arthritis: response to IL-6R blockade.

M Mohr, A M Jacobi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21961704     DOI: 10.3109/03009742.2011.599072

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  13 in total

Review 1.  Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review.

Authors:  Kundan Iqbal; Clive Kelly
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-12       Impact factor: 5.346

Review 2.  Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD).

Authors:  Adelle S Jee; Tamera J Corte
Journal:  Drugs       Date:  2019-09       Impact factor: 9.546

Review 3.  Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced.

Authors:  Robert W Hallowell; Maureen R Horton
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

Review 4.  Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.

Authors:  Rekha Vij; Mary E Strek
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

5.  Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study.

Authors:  Mitsuhiro Akiyama; Yuko Kaneko; Kunihiro Yamaoka; Harumi Kondo; Tsutomu Takeuchi
Journal:  Rheumatol Int       Date:  2016-04-12       Impact factor: 2.631

Review 6.  The multifaceted aspects of interstitial lung disease in rheumatoid arthritis.

Authors:  Lorenzo Cavagna; Sara Monti; Vittorio Grosso; Nicola Boffini; Eva Scorletti; Gloria Crepaldi; Roberto Caporali
Journal:  Biomed Res Int       Date:  2013-09-25       Impact factor: 3.411

Review 7.  Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view.

Authors:  So-My Koo; Soo-Taek Uh
Journal:  Korean J Intern Med       Date:  2017-06-30       Impact factor: 2.884

Review 8.  Therapeutic management of patients with rheumatoid arthritis and associated interstitial lung disease: case report and literature review.

Authors:  Andrea Picchianti Diamanti; Milica Markovic; Giuseppe Argento; Simonetta Giovagnoli; Alberto Ricci; Bruno Laganà; Raffaele D'Amelio
Journal:  Ther Adv Respir Dis       Date:  2016-10-12       Impact factor: 4.031

Review 9.  The safety of biologic therapies in RA-associated interstitial lung disease.

Authors:  Meghna Jani; Nik Hirani; Eric L Matteson; William G Dixon
Journal:  Nat Rev Rheumatol       Date:  2013-12-24       Impact factor: 20.543

Review 10.  Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis.

Authors:  Shunsuke Mori
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.